Related Experiment Video
Updated: Jun 13, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Down regulation of prothrombinase by activated protein C during prothrombin activation
Paul Y Kim1, Michael E Nesheim
1Department of Biochemistry, Queen's University, Kingston, Ontario, Canada.
Insights
Activated protein C (aPC) downregulates prothrombinase by inactivating factor Va (FVa). FXa and prothrombin protect FVa during this process, with protection effects being multiplicative.
Area of Science:
- Biochemistry
- Hematology
- Enzymology
Background:
- Activated protein C (aPC) is a key regulator of coagulation, primarily inactivating factor Va (FVa).
- While FVa inactivation by aPC is well-studied, its inactivation within the prothrombinase complex during thrombin generation is less understood.
Purpose of the Study:
- To investigate the inactivation of prothrombinase by aPC during prothrombin activation.
- To determine the protective effects of FXa and prothrombin on FVa within the prothrombinase complex.
Main Methods:
- Prothrombin activation was monitored using fluorescence assays with varying concentrations of aPC, FVa, and FXa.
- Rate constants for prothrombinase and FVa inactivation were determined under different conditions, including the presence of protein S.
Main Results:
- Prothrombinase inactivation by aPC followed pseudo first-order kinetics.
- FVa is significantly protected (101-fold) from aPC inactivation when limiting in the prothrombinase complex, with FXa and prothrombin contributing multiplicatively to this protection.
- When FVa is in excess, protection diminishes, indicating a reduced role for FXa.
Conclusions:
- aPC downregulates FVa activity during prothrombin activation.
- FXa and prothrombin provide multiplicative protection to FVa within the prothrombinase complex.
- Protein S influences the rate of prothrombinase inactivation but does not abolish FVa protection.
Abstract:
Activated protein C (aPC) proteolytically inactivates factor Va (FVa) and thereby downregulates prothrombinase. Although FVa inactivation by aPC has been studied extensively, the inactivation of prothrombinase during prothrombin activation has not. Therefore, prothrombin activation initiated both without and with aPC (5.0, 7.5 or 10.0 nM) was monitored over time by fluorescence. The experiments were performed with 0.075 nM FVa and 1.0 nM FXa, and with these concentrations reversed. The time courses of the residual prothrombinase activity with aPC, determined from the slopes of fluorescence over time, were pseudo first order with both limiting and excess FVa. With FVa limiting or in excess, the second rate constants for inactivation of prothrombinase were 1.98 +/- 0.09 x 10(5) M(-1)s(-1) and 2.54 +/- 0.13 x 10(5) M(-1)s(-1), respectively. The former value is 101-fold smaller than that for FVa inactivation by aPC alone. Since with limiting FVa the second order rate constants for prothrombinase inactivation and FVa inactivation are equal, FVa is protected 101-fold, presumably by both FXa and prothrombin. In contrast, with excess FVa, the calculated rate constant for FVa inactivation exceeds that for prothrombinase inactivation 17.3-fold, which reflects a loss of protection by FXa. Since the protective effects of the two proteins are theoretically multiplicative, FXa protected 17.3-fold and prothrombin protected 5.8-fold. With 150 nM protein S and limiting FVa, prothrombinase inactivation was two-fold faster, yet it was still protected 91-fold. These studies show that FVa is down-regulated by aPC during prothrombin activation, but both FXa and prothrombin protect FVa in a multiplicative way, with or without protein S.
More Related Videos
Related Concept Videos
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Amplifying Signals via Enzymatic Cascade

